Giant Cell Arteritis

An 84-year-old woman presented to the Tufts Medical Center emergency department with a chief complaint of blurred vision in the right eye.

Tapering tocilizumab leads to a longer relapse-free period in patients with giant cell arteritis, compared with abrupt discontinuation, according to data published in Seminars in Arthritis and Rheumatism.

Glucocorticoids are an effective go-to treatment for giant cell arteritis, but discontinuing them can be difficult, according to a presenter at the 2024 AWIR annual conference.

Nearly all rheumatologists who responded to a recent survey reported patients with giant cell arteritis are in dire need of new treatments, according to a market analysis from Spherix Global Insights.

Diplopia should raise clinician suspicion for giant cell arteritis when associated with cephalic symptoms and prompt the use of corticosteroids to prevent ocular ischemic complications, according to researchers.

KIAWAH ISLAND, S.C. — Temporal artery ultrasound and EULAR score are reliable means for diagnosing giant cell arteritis, Mercy Bechtold, MD, said during her presentation at Kiawah Eye.

DESTIN, Fla. — Rheumatologists should consider tapering tocilizumab for patients with giant cell arteritis in remission despite the increased risk for flare, said a speaker at the Congress of Clinical Rheumatology East annual meeting.

All diagnoses of giant cell arteritis made through temporal artery ultrasound were unchanged at 1 month — and at 2 years, for those with available data — in a study published in Annals of Internal Medicine.

A new metric reliably confirms giant cell arteritis in suspected cases by combining a validated clinical scoring tool with ultrasonography, according to data in The Lancet Rheumatology.

Nearly half of patients with giant cell arteritis who received upadacitinib while tapering steroids achieved remission from weeks 12 through 52 in a phase 3 trial, according to a press release from AbbVie.